Neuroblastoma aggressiveness in relation to sympathetic neuronal differentiation stage.

Sofie Mohlin, Caroline Wigerup, Sven Påhlman

Research output: Contribution to journalArticlepeer-review

20 Citations (SciVal)
437 Downloads (Pure)


Neuroblastoma is a childhood malignancy of the sympathetic neuronal lineage. It is a rare disease, but since it is frequently diagnosed during infancy, neuroblastoma causes life-long medical follow up of those children that survive the disease. It was early recognized that a high tumor cell differentiation stage correlates to favorable clinical stage and positive clinical outcome. Today, highly differentiated tumors are surgically removed and not further treated. Cells of many established human neuroblastoma cell lines have the capacity to differentiate when stimulated properly, and these cell lines have been used as models for studying and understanding central concepts of tumor cell differentiation. One recent aspect of this issue is the observation that tumor cells can dedifferentiate and gain a stem cell-like phenotype during hypoxic conditions, which was first shown in neuroblastoma. Aberrant or blocked differentiation is a central aspect of neuroblastoma genesis. In this review we summarize known genetic and non-genetic events in neuroblastoma that might be coupled to an aberrant sympathetic neuronal differentiation and thereby indirectly influencing tumorigenesis and/or aggressive neuroblastoma behavior.
Original languageEnglish
Pages (from-to)276-282
JournalSeminars in Cancer Biology
Issue number4
Publication statusPublished - 2011

Bibliographical note

The information about affiliations in this record was updated in December 2015.
The record was previously connected to the following departments: Molecular Medicine (013031200)

Subject classification (UKÄ)

  • Cancer and Oncology


Dive into the research topics of 'Neuroblastoma aggressiveness in relation to sympathetic neuronal differentiation stage.'. Together they form a unique fingerprint.

Cite this